Axsome Therapeutics, Inc. (AXSM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 191.2M | 196M | 170.99M | 150.04M | 121.46M | 118.77M | 104.76M | 87.17M | 75M | 71.53M | 57.79M | 46.7M | 94.58M | 24.37M | 16.85M | 8.82M | 0 | 0 | 0 | 0 |
| Revenue Growth % | 57.42% | 65.03% | 63.22% | 72.13% | 61.95% | 66.04% | 81.27% | 86.65% | -20.7% | 193.5% | 243.07% | 429.48% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 14.72M | 12.33M | 11.91M | 13.45M | 9.79M | 10.51M | 8.44M | 8.05M | 6.3M | 7.38M | 6.53M | 4.6M | 7.56M | 2.29M | 1.92M | 983K | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 7.7% | 6.29% | 6.97% | 8.96% | 8.06% | 8.85% | 8.05% | 9.24% | 8.4% | 10.31% | 11.3% | 9.85% | 7.99% | 9.4% | 11.42% | 11.15% | - | - | - | - |
| Gross Profit | 176.48M | 183.67M | 159.08M | 136.59M | 111.67M | 108.25M | 96.33M | 79.11M | 68.7M | 64.15M | 51.26M | 42.1M | 87.02M | 22.08M | 14.92M | 7.84M | 0 | 0 | 0 | 0 |
| Gross Margin % | 92.3% | 93.71% | 93.03% | 91.04% | 91.94% | 91.15% | 91.95% | 90.76% | 91.6% | 89.69% | 88.7% | 90.15% | 92.01% | 90.6% | 88.58% | 88.85% | - | - | - | - |
| Gross Profit Growth % | 58.03% | 69.67% | 65.15% | 72.66% | 62.55% | 68.74% | 87.91% | 87.91% | -21.05% | 190.54% | 243.53% | 437.21% | - | - | - | - | - | - | - | - |
| Operating Expenses | 239.84M | 213.1M | 205.19M | 173.31M | 168.66M | 180.87M | 158.95M | 157.16M | 135.98M | 162.43M | 113.38M | 107.16M | 93.39M | 82M | 57.33M | 47.02M | 38.29M | 32.61M | 33.41M | 30.85M |
| OpEx % of Revenue | 125.43% | 108.73% | 120% | 115.51% | 138.85% | 152.29% | 151.72% | 180.3% | 181.31% | 227.07% | 196.18% | 229.46% | 98.75% | 336.45% | 340.34% | 533.08% | - | - | - | - |
| Selling, General & Admin | 185M | 169.3M | 150.24M | 130.28M | 120.79M | 113.27M | 95.56M | 103.55M | 98.97M | 86.81M | 83.19M | 78.94M | 74.19M | 61.5M | 40.89M | 31.16M | 25.7M | 18.83M | 20.23M | 16.34M |
| SG&A % of Revenue | 96.75% | 86.38% | 87.86% | 86.83% | 99.44% | 95.37% | 91.22% | 118.8% | 131.96% | 121.36% | 143.94% | 169.03% | 78.45% | 252.33% | 242.74% | 353.29% | - | - | - | - |
| Research & Development | 52.68M | 48.79M | 40.16M | 49.54M | 44.78M | 55.01M | 45.39M | 49.85M | 36.83M | 30.8M | 28.77M | 20.58M | 17.79M | 14.69M | 14.88M | 15.79M | 12.59M | 13.78M | 13.18M | 14.5M |
| R&D % of Revenue | 27.55% | 24.89% | 23.49% | 33.02% | 36.87% | 46.31% | 43.32% | 57.19% | 49.11% | 43.06% | 49.78% | 44.07% | 18.81% | 60.29% | 88.31% | 179.05% | - | - | - | - |
| Other Operating Expenses | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 177K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 66K | 0 | 0 | 0 | 0 |
| Operating Income | -63.36M | -29.43M | -46.11M | -36.71M | -56.98M | -72.62M | -62.62M | -78.05M | -67.28M | -98.27M | -62.12M | -65.06M | -6.37M | -59.92M | -42.41M | -39.18M | -38.29M | -32.61M | -33.41M | -30.85M |
| Operating Margin % | -33.14% | -15.02% | -26.97% | -24.47% | -46.91% | -61.14% | -59.78% | -89.54% | -89.7% | -137.39% | -107.49% | -139.31% | -6.74% | -245.85% | -251.76% | -444.23% | - | - | - | - |
| Operating Income Growth % | -11.19% | 59.47% | 26.37% | 52.96% | 15.3% | 26.11% | -0.81% | -19.97% | -955.46% | -64.02% | -46.47% | -66.04% | 83.35% | -83.75% | -26.95% | -27.01% | -37.51% | -17.53% | -58.13% | -73.51% |
| EBITDA | -61.08M | -27.16M | -44.38M | -34.47M | -54.85M | -70.54M | -60.56M | -76.05M | -65.44M | -96.53M | -60.38M | -62.91M | -4.71M | -57.9M | -40.73M | -38.79M | -37.98M | -32.3M | -33.11M | -30.57M |
| EBITDA Margin % | -31.95% | -13.86% | -25.96% | -22.97% | -45.16% | -59.4% | -57.81% | -87.25% | -87.26% | -134.96% | -104.47% | -134.71% | -4.98% | -237.57% | -241.79% | -439.77% | - | - | - | - |
| EBITDA Growth % | -11.37% | 61.5% | 26.72% | 54.68% | 16.19% | 26.92% | -0.31% | -20.89% | -1288.88% | -66.72% | -48.23% | -62.19% | 87.59% | -79.25% | -23.03% | -26.88% | -37.73% | -16.68% | -56.75% | -72% |
| D&A (Non-Cash Add-back) | 2.27M | 2.27M | 1.73M | 2.25M | 2.13M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 2.15M | 1.66M | 2.02M | 1.68M | 393.35K | 312K | 307.41K | 299.74K | 277.42K |
| EBIT | -63.36M | -26.96M | -46.11M | -44.82M | -56.98M | -72.62M | -62.62M | -78.05M | -67.28M | -98.27M | -62.12M | -65.06M | -6.37M | -59.92M | -42.41M | -39.18M | -38.29M | -32.61M | -33.41M | -30.85M |
| Net Interest Income | -1.19M | 865K | -1.12M | -1.83M | -2.43M | -2.21M | -1.98M | -1.3M | -1.08M | -702K | -757K | -2.73M | -2.26M | -1.32M | -2.41M | -2.26M | -1.34M | -1.37M | -1.48M | -1.44M |
| Interest Income | 0 | 2.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.19M | 1.17M | 1.12M | 1.83M | 2.43M | 2.21M | 1.98M | 1.3M | 1.08M | 702K | 757K | 2.73M | 2.26M | 1.32M | 2.41M | 2.26M | 1.34M | 1.37M | 1.48M | 1.44M |
| Other Income/Expense | -1.19M | 1.3M | -1.12M | -12.22M | -2.43M | -2.21M | -1.98M | -1.3M | -1.08M | -702K | -757K | -2.73M | -2.26M | -1.32M | -2.41M | -2.26M | -1.34M | -1.37M | -1.48M | -1.44M |
| Pretax Income | -64.54M | -28.13M | -47.23M | -48.93M | -59.41M | -74.83M | -64.6M | -79.34M | -68.36M | -98.98M | -62.88M | -67.79M | -8.64M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M |
| Pretax Margin % | -33.76% | -14.35% | -27.62% | -32.61% | -48.91% | -63% | -61.67% | -91.03% | -91.14% | -138.37% | -108.8% | -145.15% | -9.13% | -251.28% | -266.08% | -469.82% | - | - | - | - |
| Income Tax | 0 | 430K | 0 | -960K | 0 | 85K | 0 | 0 | 0 | -325K | -678K | -617K | 2.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -1.53% | 0% | 1.96% | 0% | -0.11% | 0% | 0% | 0% | 0.33% | 1.08% | 0.91% | -29.87% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M |
| Net Margin % | -33.76% | -14.57% | -27.62% | -31.97% | -48.91% | -63.08% | -61.67% | -91.03% | -91.14% | -137.92% | -107.62% | -143.83% | -11.86% | -251.28% | -266.08% | -469.82% | - | - | - | - |
| Net Income Growth % | -8.63% | 61.88% | 26.89% | 39.54% | 13.08% | 24.06% | -3.86% | -18.13% | -509.35% | -61.09% | -38.77% | -62.1% | 71.69% | -80.24% | -28.5% | -28.35% | -35.45% | -16.5% | -52.16% | -76.16% |
| Net Income (Continuing) | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 | -1.07 | -1.06 | -1.03 | -0.90 | -0.93 | -0.86 |
| EPS Growth % | -3.28% | 63.64% | 29.85% | 41.92% | 15.28% | 25.96% | -1.52% | -8.44% | -453.85% | -47.52% | -23.36% | -45.28% | 74.76% | -56.67% | -15.05% | -23.26% | -32.05% | -15.38% | -52.46% | -75.51% |
| EPS (Basic) | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 | -1.07 | -1.06 | -1.03 | -0.90 | -0.93 | -0.86 |
| Diluted Shares Outstanding | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M |
| Basic Shares Outstanding | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |